Antituberculosis chemotherapy
著者
書誌事項
Antituberculosis chemotherapy
（Progress in respiratory research, v. 40）
Karger, 2011
- hard cover : alk.
- eISBN
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and indexes
収録内容
- History of drug discovery : early evaluation studies and lessons learnt from them / Ahmad, Z., Makaya, N.H. and Grosset, J.
- Tuberculosis treatment trials past and present : old and new challenges / Nunn, N.
- The rifamycins : renewed interest in an old drug class / Burman, W., Dooley, K.E., and Nuermberger, E.
- Isoniazid pharmacokinetics and efficacy in adults and children / Donald, P.R. and Schaaf, H.S.
- Recent developments in the study of pyrazinamide : an update / Mitchison, D.A. and Zhang, Y.
- Experience with phase III clinical trials of antituberculosis drugs and regimens : conclusions and lessons for the future / Jindani, A.
- Tuberculosis recurrence : exogenous or endogenous? / Williams, M. ... [et al.]
- Second-line antituberculosis drugs : current knowledge, recent research findings and controversies / Schaaf, H.S., Seddon, J.A., and Caminero, J.A.
- Acquisition, transmission, and amplification of drug-resistant tuberculosis / Müller, B. ... [et al.]
- The treatment of tuberculosis in children
- Cruz, A.T. and Starke, J.R.
- Issues and challenges in the development of novel tuberculosis drug regimens / Erondu, N. and Ginsberg, A.
- Drug resistance in mycobacterium tuberculosis : molecular mechanisms and laboratory susceptibility testing / Bittger, E.C.
- The role of the mouse model in the evaluation of new antituberculosis drugs / Nuermberger, E.L.
- Current issues in tuberculosis pharmacokinetics / Egelund, E.F. and Peloquin, C.A.
- Pharmacological considerations of antitubercular agents in children / Goldman, J.L., Kearns, G.L., and Abdel-Rahman, S.M.
- Interactions between antituberculosis and antiretroviral agents / Mcilleron, H. and Khoo, S.H.
- Diabetes mellitus and tuberculosis treatment / Ruslami, R., Van Crevel, R.
- Early bactericidal activity of antituberculosis agents / Maritz, J.Z., Diacon, A.H., and Donald, P.R.
- Assessment of whole-blood bactericidal activity in the evaluation of new antituberculosis drugs / Wallis, R.S.
- Serial sputum colony counting in drug regimens / Sloan, D. and Davies, G.
- The evaluation of new antituberculosis drugs in children / Mcneeley, D.F. ... [et al.]
- A new era in tuberculosis treatment : what does the future hold? / Duncan, K
内容説明・目次
- 巻冊次
-
hard cover : alk. ISBN 9783805596275
内容説明
Tuberculosis (TB) remains one of the major infectious diseases of mankind although drugs for its treatment have been available for nearly 60 years. The standard short-course 6-month regimen used since about 1980 has helped to save millions of lives, but co-infection with HIV has had a devastating effect on the epidemic, and multidrug-resistant TB is a growing problem, particularly in communities with a high incidence of HIV. Following the declaration by the WHO in the early 1990s that TB was a 'global health emergency', interest in TB research and the development of new drugs has increased significantly. This volume reviews anti-TB chemotherapy with the emphasis on the actions and pharmacology of existing drugs and the development and evaluation of new agents. A close look is taken at new research regarding our existing drugs by some of the best-known specialists in the field, and historical aspects of these agents are reviewed from a modern perspective. The prospects for the introduction of new drugs and different approaches of how to assess them in adults and in children are discussed in detail. Several papers address the problems associated with drug resistance, its spread and diagnosis. Compiled by two editors from Cape Town, which has a particularly high incidence of TB and is a centre of tuberculosis research, this publication is an indispensable reference for anyone involved in the management of TB either as a researcher, clinician or administrator, and those working in drug development.
目次
- Retrospectoscope
- History of Drug Discovery: Early Evaluation Studies and Lessons Learnt from Them: Ahmad, Z.
- Makaya, N.H.
- Grosset, J.
- Tuberculosis Treatment Trials Past and Present: Old and New Challenges: Nunn, N.
- Present Treatment
- The Rifamycins: Renewed Interest in an Old Drug Class: Burman, W.
- Dooley, K.E.
- Nuermberger, E.L.
- Isoniazid Pharmacokinetics and Efficacy in Adults and Children: Donald, P.R.
- Schaaf, H.S.
- Recent Developments in the Study of Pyrazinamide: An Update: Mitchison, D.A.
- Zhang, Y.
- Experience with Phase III Clinical Trials of Antituberculosis Drugs and Regimens: Conclusions and Lessons for the Future: Jindani, A.
- Fluoroquinolones in the Management of Tuberculosis: Singh, K.P.
- Gillespie, S.H.
- Current Standard Treatment: Vernon, A.A.
- Tuberculosis Recurrence: Exogenous or Endogenous?: Williams, M. et al.
- Second-Line Antituberculosis Drugs: Current Knowledge, Recent Research Findings and Controversies: Schaaf, H.S. et al.
- Acquisition, Transmission and Amplification of Drug-Resistant Tuberculosis: Muller, B. et al.
- The Treatment of Tuberculosis in Children: Cruz, A.T.
- Starke, J.R.
- The Future
- Issues and Challenges in the Development of Novel Tuberculosis Drug Regimens: Erondu, N.
- Ginsberg, A.
- Drug Resistance in Mycobacterium tuberculosis: Molecular Mechanisms and Laboratory Susceptibility Testing: Bottger, E.C.
- The Role of the Mouse Model in the Evaluation of New Antituberculosis Drugs: Nuermberger, E.L.
- Current Issues in Tuberculosis Pharmacokinetics: Egelund, E.F.
- Peloquin, C.A.
- Pharmacological Considerations of Antitubercular Agents in Children: Goldman, J.L. et al.
- Pharmacogenetics of Antituberculosis Drugs: Aarnoutse, R.
- Interactions between Antituberculosis and Antiretroviral Agents: McIlleron, H.
- Khoo, S.H.
- Diabetes Mellitus and Tuberculosis Treatment: Ruslami, R.
- van Crevel, R.
- Early Bactericidal Activity of Antituberculosis Agents: Diacon, A.H.
- Maritz, J.Z.
- Donald, P.R.
- Assessment of Whole-Blood Bactericidal Activity in the Evaluation of New Antituberculosis Drugs: Wallis, R.S.
- Serial Sputum Colony Counting in Drug Development: Sloan, D.
- Davies, G.
- The Evaluation of New Antituberculosis Drugs in Children: McNeeley, D.F. et al.
- A New Era in Tuberculosis Treatment: What Does the Future Hold?: Duncan, K.
- Author Index
- Subject Index.
- 巻冊次
-
eISBN ISBN 9783805596282
内容説明
Tuberculosis (TB) remains one of the major infectious diseases of mankind although drugs for its treatment have been available for nearly 60 years. The standard short-course 6-month regimen used since about 1980 has helped to save millions of lives, but co-infection with HIV has had a devastating effect on the epidemic, and multidrug-resistant TB is a growing problem, particularly in communities with a high incidence of HIV. Following the declaration by the WHO in the early 1990s that TB was a 'global health emergency', interest in TB research and the development of new drugs has increased significantly. This volume reviews anti-TB chemotherapy with the emphasis on the actions and pharmacology of existing drugs and the development and evaluation of new agents. A close look is taken at new research regarding our existing drugs by some of the best-known specialists in the field, and historical aspects of these agents are reviewed from a modern perspective. The prospects for the introduction of new drugs and different approaches of how to assess them in adults and in children are discussed in detail. Several papers address the problems associated with drug resistance, its spread and diagnosis. Compiled by two editors from Cape Town, which has a particularly high incidence of TB and is a centre of tuberculosis research, this publication is an indispensable reference for anyone involved in the management of TB either as a researcher, clinician or administrator, and those working in drug development.
「Nielsen BookData」 より
